Citizens Financial Group’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$478K Buy
8,793
+2,188
+33% +$107K 0.01% 674
2026
Q1
$283K Buy
+6,605
New +$284K ﹤0.01% 709
2020
Q3
Sell
-240
Closed -$6K 467
2020
Q2
$6K Sell
240
-281
-54% -$6.51K ﹤0.01% 856
2020
Q1
$9K Buy
521
+394
+310% +$7.21K ﹤0.01% 769
2019
Q4
$2K Buy
+127
New +$2.15K ﹤0.01% 960

Other funds holding EXEL

Citizens Financial Group's EXEL Position: Q2 2026 in Review

Citizens Financial Group increased its Exelixis (EXEL) stake by 33% in Q2 2026, buying an estimated $107K and bringing the position to 8,793 shares worth $478K. The position accounts for 0.01% of the portfolio, ranked #674.

Citizens Financial Group first reported a position in EXEL in Q4 2019 and has held it in 5 quarters since. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Citizens Financial Group held 8,793 shares of Exelixis worth $478K as of Q2 2026.
  • Citizens Financial Group bought 2,188 Exelixis shares in Q2 2026, an estimated $107K.
  • Exelixis made up 0.01% of Citizens Financial Group's portfolio in Q2 2026, its #674 holding.
  • Citizens Financial Group first reported a position in Exelixis in Q4 2019 and has held it in 5 quarters since.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Citizens Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.